drugset / Trial / NCT00013897

A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine

NCT00013897

Phase 3 Completed Bristol-Myers Squibb
Double-blindTreatment

Summary

The purpose of this study is to compare the effectiveness of treatment with BMS-232632 to that of efavirenz (EFV) when both are used with zidovudine (ZDV) and lamivudine (3TC).

Timeline

Start
2001-02
Primary completion
2003-04
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Atazanavir Other / unclassified
Subject Efavirenz Other / unclassified
Background Lamivudine Other / unclassified
Background Zidovudine Small molecule